Literature DB >> 20444728

Myxoid adrenal cortical carcinoma presenting as primary hyperaldosteronism: case report and review of the literature.

Min-Shu Hsieh1, Jun-Herng Chen, Long-Wei Lin.   

Abstract

The authors report a case of myxoid adrenal cortical carcinoma (ACC) clinically manifesting as primary hyperaldosteronism. The 82-year-old female patient had a history of hypertension and was sent to the emergency room because of change in consciousness. Ventricular fibrillation occurred, and severe hypokalemia was found. Increased renal loss of potassium, high serum aldosterone level, low renin activity, and a huge tumor in the left suprarenal area were revealed when tests were conducted to determine the cause of her hypokalemia. Left adrenalectomy was performed. The tumor measured 13 cm in diameter and showed a heterogeneous cut surface with gelatinous material. Microscopically, the lesion was composed of polygonal cells with eosinophilic cytoplasm and arranged in arborizing cords in a myxoid background. Capsular and vascular invasion were observed. The tumor stained positive for synaptophysin, melan-A, vimentin, and α-inhibin but negative for cytokeratin. A primary myxoid ACC was diagnosed, which is a rare histological variant. The authors review 13 other reported cases. Most of these were functional tumors causing Cushing syndrome, and only 2 cases presented as primary hyperaldosteronism. All cases had similar microscopic and immunohistochemical features. Distal metastases and local recurrence were not uncommon. Close clinical follow-up is imperative.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444728     DOI: 10.1177/1066896909356925

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  7 in total

Review 1.  Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.

Authors:  Adrienne Carruth Griffin; Rachel Kelz; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 2.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

Review 3.  [New aspects of tumor pathology of the adrenal glands].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  Adrenal cancer: relevance of different grading systems and subtypes.

Authors:  S Minner; J Schreiner; W Saeger
Journal:  Clin Transl Oncol       Date:  2021-04-05       Impact factor: 3.405

5.  Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.

Authors:  Tae Yon Sung; Yun Mi Choi; Won Gu Kim; Yu Mi Lee; Tae Yong Kim; Young Kee Shong; Won Bae Kim; Dong Eun Song
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

Review 6.  Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Authors:  Alfred King-Yin Lam
Journal:  Biomedicines       Date:  2021-02-10

Review 7.  Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Authors:  Ozgur Mete; Lori A Erickson; C Christofer Juhlin; Ronald R de Krijger; Hironobu Sasano; Marco Volante; Mauro G Papotti
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 4.056

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.